As of November 10, 2026, Turn Therapeutics Inc. is a publicly traded company (Nasdaq: TTRX). Bradley Burnam, the executive officer and a director, reports holding 52.76%, a majority of its shares. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13G, April 6, 2026).
Is this your company?
About to sign with, pay or invest in Turn Therapeutics Inc.? See the free Snapshot first.
Free to see. No signup.
Is Turn Therapeutics Inc. a real, registered company?
- Turn Therapeutics Inc. files with the SEC under CIK 2023016 (its SEC filings).
- Its shares are listed under the ticker TTRX on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Westlake Village, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Turn Therapeutics Inc. in our court records and SEC 8-K records (as of 2026-11-10).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Bradley Burnam (filed 2026-04-06).
Who are Turn Therapeutics Inc.'s owners and officers?
Turn Therapeutics Inc.: incorporated in Delaware; business address in Westlake Village, California; industry Pharmaceutical Preparations (Form D, 2026-08-26).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2026-08-26)
- : Executive Officer (Form D, 2026-08-26)
- : Director (Form D, 2026-08-26)
- : Director (Form D, 2026-08-26)
- : Director (Form D, 2026-08-26)
- : Director (Form D, 2026-08-26)
- : Executive Officer, Director (Form D, 2026-08-26)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-04-06 | Bradley Burnam | 52.76% |
Want the whole picture on Turn Therapeutics Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Turn Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Turn Therapeutics Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Turn Therapeutics Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and a director: 15,416,260 shares (50.4% of shares outstanding), held indirectly through By BEB Holdings, LLC, on a joint filing (Form 4, 2026-06-01).
- BEB Holdings, LLC, a 10% owner: 15,416,260 shares (50.4% of shares outstanding), held indirectly through By BEB Holdings, LLC, on a joint filing (Form 4, 2026-06-01).
- Abraham Chesed: 1,447,268 shares (4.7% of shares outstanding), held indirectly through an anc merchant flp and anc carlson flp (Form 4, 2025-10-29).
- , a director: 360,602 shares (1.2% of shares outstanding) (Form 4, 2026-04-03).
- , a director: 21,882 shares (0.07% of shares outstanding) (Form 4, 2026-02-04).
Shares outstanding: 30,572,704 as of 2026-11-06, from the company's latest SEC cover page.
How much has Turn Therapeutics Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-08-26 | $1.65M | not stated |
Latest IPO step: Turn Therapeutics Inc. filed to go public (S-1, 2025-10-09).
IPO filings: S-1, 2025-10-09, 424B4, 2025-10-08, S-1/A, 2025-09-24, S-1/A, 2025-09-16, S-1, 2025-09-02; ticker TTRX on Nasdaq.
Keep reading
More on Turn Therapeutics Inc. and the records around it.
Turn Therapeutics Inc. elsewhere on the record
- Form D filing Aug 2026
- Crowdfunding filing May 2026
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/turn-therapeutics